Back
Altamira Therapeutics Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
19
CYTOF
Altamira Therapeutics
Last Price:
$0.09
Seasonality Move:
-17.35%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTOF is experiencing selling pressure, which indicates risk of future bearish movement.
Altamira Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.38 | Sell |
| 20-day SMA: | 0.42 | Sell |
| 50-day SMA: | 0.47 | Sell |
| 200-day SMA: | 1.09 | Sell |
| 8-day EMA: | 0.34 | Sell |
| 20-day EMA: | 0.41 | Sell |
| 50-day EMA: | 0.49 | Sell |
| 200-day EMA: | 3.36 | Sell |
Altamira Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 16.63 | Sell |
| Chaikin Money Flow: | -464545 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.35 - 0.49) | Sell |
| Bollinger Bands (100): | (0.44 - 0.88) | Sell |
Altamira Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Altamira Therapeutics Stock
Is Altamira Therapeutics Stock a Buy?
-
Altamira Therapeutics share price is 0.12 while CYTOF 8-day simple moving average is 0.38, which is a Sell signal.
-
The stock price of CYTOF is 0.12 while Altamira Therapeutics 20-day SMA is 0.42, which makes it a Sell.
-
Altamira Therapeutics 50-day simple moving average is 0.47 while CYTOF share price is 0.12, making it a Sell technically.
-
CYTOF stock price is 0.12 and Altamira Therapeutics 200-day simple moving average is 1.09, creating a Sell signal.
CYTOF Technical Analysis vs Fundamental Analysis
Sell
19
Altamira Therapeutics (CYTOF)
is a Sell
Is Altamira Therapeutics a Buy or a Sell?
-
Altamira Therapeutics stock is rated a SellThe current Altamira Therapeutics [CYTOF] share price is $0.12. The Score for CYTOF is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Altamira Therapeutics Stock Info
Market Cap:
452.7K
Price in USD:
0.12
Share Volume:
745.1K
Altamira Therapeutics 52-Week Range
52-Week High:
3.60
52-Week Low:
0.10
Sell
19
Altamira Therapeutics (CYTOF)
is a Sell
Altamira Therapeutics Share Price Forecast
-
What is the Altamira Therapeutics stock price today?The Altamira Therapeutics stock price is 0.12 USD today.
-
Will CYTOF stock go up or go down?Altamira Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Altamira Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Altamira Therapeutics is overvalued.
Is Altamira Therapeutics Stock a Buy?
-
Altamira Therapeutics share price is 0.12 while CYTOF 8-day exponential moving average is 0.34, which is a Sell signal.
-
The stock price of CYTOF is 0.12 while Altamira Therapeutics 20-day EMA is 0.41, which makes it a Sell.
-
Altamira Therapeutics 50-day exponential moving average is 0.49 while CYTOF share price is 0.12, making it a Sell technically.
-
CYTOF stock price is 0.12 and Altamira Therapeutics 200-day simple moving average is 3.36, creating a Sell signal.
Fundamental Analysis of Altamira Therapeutics
Is Altamira Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.76 per share.
Technical Analysis of Altamira Therapeutics
Should I short Altamira Therapeutics stock?
-
CYTOF Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Altamira Therapeutics is a Sell
-
Altamira Therapeutics Relative Strength Index (RSI) is 16.63, which suggest Altamira Therapeutics is oversold
-
The Bollinger Bands (25) for Altamira Therapeutics is (0.35 - 0.49), which suggest Altamira Therapeutics is a Sell
-
The Bollinger Bands (100) for Altamira Therapeutics is (0.44 - 0.88), which suggest Altamira Therapeutics is a Sell
* Altamira Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.